Prognostic Immune Markers in Non–Small Cell Lung Cancer—Letter
نویسندگان
چکیده
منابع مشابه
Prognostic immune markers in non-small cell lung cancer.
Tumor-associated immune responses have polarized effects in regulating tumor growth. Although a clear association has been shown between the tumor immune response and clinical outcome in colorectal and ovarian cancers, the role of immune markers for stratifying prognosis in non-small cell lung cancer (NSCLC) is less defined. Herein, we review the prognostic significance of published immune mark...
متن کاملSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.
Lung cancer is a major public health problem throughout the world. Among the most frequent cancer types (prostate, breast, colorectal, stomach, lung), lung cancer is the leading cause of cancer-related deaths worldwide. Among the two major subtypes of small cell lung cancer and nonsmall cell lung cancer (NSCLC), 85% of tumors belong to the NSCLC histological types. Small cell lung cancer is ass...
متن کاملClinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer
Recently, an association between Merkel cell polyomavirus (MCPyV) and epidermal growth factor receptor (EGFR) mutations in nonsmall cell lung cancer (NSCLC) was reported. However, the underlying carcinogenic effects and the prognosis related to MCPyV are still unclear. The aim of this study was to clarify the incidence and prognosis related to MCPyV infections in NSCLC.Tissue samples from 167 N...
متن کاملBAX and p16 are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer
BAX and p16 are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer. C. Gessner, U. Liebers, H. Kuhn, P. Stiehl, C. Witt J. Schauer, G. Wolff. #ERS Journals Ltd 2002. ABSTRACT: Clinical studies suggest prognostic relevance of p16 in nonsmall cell lung cancer (NSCLC) while conflicting results for p53 have been published. However, the importance of the a...
متن کاملPrognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer.
New biological factors have not been extensively studied in stage III nonsmall cell lung cancer (NSCLC). The aim of the present retrospective study was to determine the role of epidermal growth factor receptor (EGF-R) as a prognostic factor in stage III NSCLC, in addition to the stage and other known clinical factors. Clinical characteristics were retrieved from the patients' charts. Membrane i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2011
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-11-2103